Add to Your Calendar
On Tuesday, June 3, Whitney Meier Howard will be a panelist on “Navigating Parallel Proceedings: Strategies for Maneuvering Through BPCIA, PTAB and District Courts” at the 16th Annual Biosimilars & Innovator Biologics Conference in Boston. J. Jay Cho, Ph.D. (counsel, Patterson Belknap Webb & Tyler LLP), Katie Nolan-Stevaux (head of general litigation and associate general counsel, Genentech), and Jeanna Wacker (partner, Kirkland & Ellis LLP), will also speak.
Below is a summary of the panel.
It is no secret that BPCIA favors speed and demands certainty for approvals, but the “need for speed” can have its drawbacks. Join us in this session as we examine:
- Recent case law and developments
- Guidelines to work within the timelines of PTAB proceedings alongside a concurrent District Court action
- The factors that may influence litigation strategy, early case resolution, and market entry
- The different standards of proof
- Ways to identify market dynamics, pricing strategies, and other factors influencing update disparities
You can learn more about the summit, which will be held at the Metcalf Trustee Center at Boston University on June 2-3, 2025, here.